WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY – Get Free Report)’s stock price gapped down before the market opened on Friday. The stock had previously closed at $11.08, but opened at $10.0501. WuXi Biologics (Cayman) shares last traded at $10.50, with a volume of 1,207 shares.
Analysts Set New Price Targets
Separately, Zacks Research upgraded shares of WuXi Biologics (Cayman) to a “hold” rating in a report on Friday, August 28th. One investment analyst has rated the stock with a Hold rating. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold”.
Read Our Latest Stock Report on WXXWY
WuXi Biologics (Cayman) Stock Down 6.6%
The business has a fifty day moving average price of $12.66 and a 200 day moving average price of $10.35.
About WuXi Biologics (Cayman)
WuXi Biologics (Cayman) Inc. is a contract research, development and manufacturing organization focused on biologic medicines. Founded in 2010, the company provides services to biotechnology and pharmaceutical companies developing treatments for patients worldwide. Its services span the biologics development process, including discovery, cell-line and process development, analytical testing, and clinical and commercial manufacturing. The company works with products such as monoclonal and multispecific antibodies, recombinant proteins, and antibody-drug conjugates.
Recommended Stories
- Five stocks we like better than WuXi Biologics (Cayman)
- 3 Dividend ETFs Offering Steadier Footing in a Shaky Market
- Lazard’s New ETF Targets Monthly Income With Junk Bonds
- Cracks in the Crockery? Williams-Sonoma Insiders Sell Shares
- Apple’s Rare Samsung Memory Plan Could Solve One Problem and Create Another
Receive News & Ratings for WuXi Biologics (Cayman) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WuXi Biologics (Cayman) and related companies with MarketBeat.com's FREE daily email newsletter.
